Last reviewed · How we verify

NCT04245891: NECS

Neonatal Evaluation of Norepinephrine Infusion in Spinal Anesthesia for Cesarean Section

Completed Last updated 29 January 2020
What this trial tests

trial in Caesarean Section;Stillbirth in 265 participants. Completed in 30 November 2017.

Timeline
1 May 2016
Primary endpoint
30 November 2017
30 November 2017

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Nīmes
StatusCompleted
Study typeOBSERVATIONAL
Enrollment265
Start date1 May 2016
Primary completion30 November 2017
Estimated completion30 November 2017

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Nīmes

Who can join

Eligibility, female only, with Caesarean Section;Stillbirth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective study aims to evaluate the fate of children born by cesarean section under spinal anesthesia with or without norepinephrine as vasopressor support for anesthesia. The main objective is to compare the initial Apgar score. The records of patients who received norepinephrine are compared to those without norepinephrine. To limit the biases of this type of study, the investigators will apply a propensity score that will include as a variable: age, ASA score, comorbidity, urgency. The patients analysed correspond to the period 2016-2017.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centre Hospitalier Universitaire de Nīmes trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04245891.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing